Virtual screening for the discovery of bioactive natural products
- PMID: 18084917
- PMCID: PMC7124045
- DOI: 10.1007/978-3-7643-8117-2_6
Virtual screening for the discovery of bioactive natural products
Abstract
In this survey the impact of the virtual screening concept is discussed in the field of drug discovery from nature. Confronted by a steadily increasing number of secondary metabolites and a growing number of molecular targets relevant in the therapy of human disorders, the huge amount of information needs to be handled. Virtual screening filtering experiments already showed great promise for dealing with large libraries of potential bioactive molecules. It can be utilized for browsing databases for molecules fitting either an established pharmacophore model or a three dimensional (3D) structure of a macromolecular target. However, for the discovery of natural lead candidates the application of this in silico tool has so far almost been neglected. There are several reasons for that. One concerns the scarce availability of natural product (NP) 3D databases in contrast to synthetic libraries; another reason is the problematic compatibility of NPs with modern robotized high throughput screening (HTS) technologies. Further arguments deal with the incalculable availability of pure natural compounds and their often too complex chemistry. Thus research in this field is time-consuming, highly complex, expensive and ineffective. Nevertheless, naturally derived compounds are among the most favorable source of drug candidates. A more rational and economic search for new lead structures from nature must therefore be a priority in order to overcome these problems. Here we demonstrate some basic principles, requirements and limitations of virtual screening strategies and support their applicability in NP research with already performed studies. A sensible exploitation of the molecular diversity of secondary metabolites however asks for virtual screening concepts that are interfaced with well-established strategies from classical pharmacognosy that are used in an effort to maximize their efficacy in drug discovery. Such integrated virtual screening workflows are outlined here and shall help to motivate NP researchers to dare a step towards this powerful in silico tool.
Similar articles
-
Virtual screening and its integration with modern drug design technologies.Curr Med Chem. 2008;15(1):37-46. doi: 10.2174/092986708783330683. Curr Med Chem. 2008. PMID: 18220761 Review.
-
High impact technologies for natural products screening.Prog Drug Res. 2008;65:175, 177-210. doi: 10.1007/978-3-7643-8117-2_5. Prog Drug Res. 2008. PMID: 18084916 Review.
-
Predictive QSAR modeling workflow, model applicability domains, and virtual screening.Curr Pharm Des. 2007;13(34):3494-504. doi: 10.2174/138161207782794257. Curr Pharm Des. 2007. PMID: 18220786 Review.
-
Integrated in silico tools for exploiting the natural products' bioactivity.Planta Med. 2006 Jun;72(8):671-8. doi: 10.1055/s-2006-941506. Epub 2006 Jun 19. Planta Med. 2006. PMID: 16783689 Review.
-
Strategies for efficient lead structure discovery from natural products.Curr Med Chem. 2006;13(13):1491-507. doi: 10.2174/092986706777442075. Curr Med Chem. 2006. PMID: 16787200 Review.
Cited by
-
Design and optimization of SPR-based binding assay for evaluation and screening of MITF-E-box binding inhibitor.Mol Biotechnol. 2014 Mar;56(3):265-73. doi: 10.1007/s12033-013-9705-1. Mol Biotechnol. 2014. PMID: 24078219
-
Chemical constituents from coconut waste and their in silico evaluation as potential antiviral agents against SARS-CoV-2.S Afr J Bot. 2021 Sep;141:278-289. doi: 10.1016/j.sajb.2021.05.018. Epub 2021 May 28. S Afr J Bot. 2021. PMID: 34092840 Free PMC article.
-
Molecular Dynamics of Sialic Acid Analogues and their Interaction with Influenza Hemagglutinin.Indian J Pharm Sci. 2010 Jul;72(4):449-57. doi: 10.4103/0250-474X.73919. Indian J Pharm Sci. 2010. PMID: 21218055 Free PMC article.
-
Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors.Mem Inst Oswaldo Cruz. 2015 Nov;110(7):847-64. doi: 10.1590/0074-02760150239. Mem Inst Oswaldo Cruz. 2015. PMID: 26560977 Free PMC article. Review.
-
Counting on natural products for drug design.Nat Chem. 2016 Jun;8(6):531-41. doi: 10.1038/nchem.2479. Epub 2016 Apr 25. Nat Chem. 2016. PMID: 27219696 Review.
References
-
- Smith A. Screening for drug discovery: the leading question. Nature. 2002;418:453–459. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous